Veradermics, Inc MANE

Rank #1242 · NYSE · $5.8B market cap

⚠ Going-concern flag — the auditor (Deloitte & Touche LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

51.3

P/E

-220.3

P/B

-262.39

ROE

119.1%

Op. Margin

–%

Debt Ratio

-21%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -220.3x, P/B -262.39x. Ranks in the top 82% of the universe.

Profitability ★★★★★

Excellent

ROE 119.1%. Ranks in the top 3% of the universe.

Safety ★★★★★

Excellent

Debt ratio -21%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2025	–	$-0.0B	$-0.0B	$-0.0B	–	-21

← See the full screener